REMICADE® can change the course of Psoriatic Arthritis (PsA)
If you've been diagnosed with PsA, REMICADE® may be able to help. In clinical trials, for many patients, REMICADE® was shown to improve the symptoms of PsA, including:
- Inflammation and swelling of the joints at the ends of the fingers or toes
- Lasting pain and stiffness in the lower back or knees
- Inflammation in the tendons or ligaments of the heels or elbows
REMICADE® has also been shown to stop the progression of joint damage.
As with any medication, it's important to keep your doctor informed about the impact of REMICADE® on your symptoms.
More about REMICADE®
REMICADE® has been used to treat more than 1.3 million people worldwide who have inflammatory conditions, such as PsA, rheumatoid arthritis, plaque psoriasis, adult and pediatric Crohn's disease, ulcerative colitis, and ankylosing spondylitis.
REMICADE® is given as an IV infusion in about 2 hours by a healthcare professional. After your 3 starter doses, you'll need REMICADE® only once every 8 weeks.
REMICADE®, like other medicines that affect your immune system, is a strong medicine that can cause serious side effects. Please read the Important Safety Information and the Medication Guide  for REMICADE®, and discuss any questions or symptoms with your doctor.
Ask your dermatologist or rheumatologist if REMICADE® is right for you.